Susanna Jonkka joined MSK’s Office of Technology Development as an Immunotherapy Project Manager in 2022.
Prior to joining MSK, Susanna was a Medical Advisor in Oncology at the Finnish affiliate of Merck KGaA. Her previous experience also includes serving in a Nordic QARA role at Zimmer Biomet and central laboratory.
Susanna holds an M.S. in Translational Medicine from the University of Helsinki and an M.S. in Economics and Business Administration from Aalto University. During her studies she worked in ovarian cancer research to identify novel genetic drivers of high grade serous ovarian cancer and on the utilization of Shared Decision-Making models within cancer patients in Finland.